IP Library Granted Patent US 8,895,312
Granted Patent B2
US 8,895,312 · App. 13/963,813 · Granted Nov 25, 2014

Nanofluidic platform for single mitochondria analysis

Inventors: Peter Burke (Irvine, CA); Katayoun Zand (Irvine, CA); Ted Pham (Westminster, CA); Antonio Davila (Philadelphia, PA); Douglas Wallace (Swarthmore, PA)
Assignee: The Regents of the University of California
G01N33/582B01L3/502761B01L2300/123B01L2200/0668B01L2300/0861G01N33/5005G01N15/1484B01L2300/0816
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,895,312
App. No.
13/963,813
Granted
Nov 25, 2014
Kind
B2
Abstract

A microfluidic device for mitochondria analysis includes an inlet coupled to a first access channel, an outlet coupled to a second access channel, and a plurality of trapping channels fluidically coupled at one end to the first access channel and fluidically coupled at an opposing end to the second access channel, each trapping channel has a cross-sectional dimension about 2 μm in one direction and a cross-sectional dimension between about 0.45 and about 0.75 μm in a second direction.

Claims (26)

1. A microfluidic device for mitochondria analysis comprising:

an inlet coupled to a first access channel;

an outlet coupled to a second access channel; and

a plurality of trapping channels fluidically coupled at one end to the first access channel and fluidically coupled at an opposing end to the second access channel, each trapping channel comprises a cross-sectional dimension about 2 μm in one of width or height and a cross-sectional dimension between about 0.45 and about 0.75 μm in the other of width or height.

2. The microfluidic device of claim 1 , wherein the trapping channels are formed in polydimethysiloxane PDMS.

3. The microfluidic device of claim 1 , further comprising a pumping source operatively coupled to the inlet.

4. The microfluidic device of claim 1 , wherein the plurality of trapping channels comprises at least five channels.

5. The microfluidic device of claim 1 , further comprising an imaging device configured to image the plurality of trapping channels.

6. The microfluidic device of claim 1 , wherein each of the trapping channels has a trapezoidal cross-sectional shape.

7. A method of analyzing mitochondria comprising:

flowing a sample containing mitochondria into the inlet of the device of claim 1 ;

trapping at least some of the mitochondria within the trapping channels; and

imaging the plurality of trapping channels with an imaging device, wherein the trapped mitochondria are fluorescently labeled.

8. The method of claim 7 , wherein imaging comprises obtaining multiple images over a period of time and monitoring fluorescent levels as a function of time.

9. The method of claim 7 , wherein in the sample containing mitochondria also contains substrates consumed by the mitochondria.

10. The method of claim 7 , further comprising serially flowing different solutions through the inlet of the device.

11. The method of claim 7 , wherein the sample is flowed into the device at a rate of around 10 μL/h.

12. The method of claim 7 , wherein multiple mitochondria are trapped within the trapping channels.

13. The method of claim 12 , wherein each trapping channel traps between about 3 and 6 mitochondria within a field of view of the imaging device.

14. A method of analyzing mitochondria comprising:

flowing a sample containing fluorescently labeled mitochondria through a plurality of trapping channels, with each trapping channel having a cross-sectional dimension about 2 μm in one of width or height and a cross-sectional dimension between about 0.45 and about 0.75 μm in the other of width or height;

trapping one or more mitochondria within the plurality of trapping channels; and

imaging the trapped one or more mitochondria over a period of time.

15. The method of claim 14 , wherein imaging comprises obtaining multiple images over a period of time and monitoring fluorescent levels as a function of time.

16. The method of claim 14 , wherein the sample containing mitochondria also contains substrates consumed by the mitochondria.

17. The method of claim 14 , further comprising serially flowing different solutions through the plurality of trapping channels.

Assignments (2)
CONFIRMATORY LICENSE Recorded Jun 19, 2014
From: UNIVERSITY OF CALIFORNIA SYS OFFICE/PRES
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 033212/0904 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 18, 2014
From: BURKE, PETER; ZAND, KATAYOUN; PHAM, TED
To: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Reel/Frame 032275/0929 →
Continuity (2)
Provisional Application 61691165 · Aug 20, 2012
Related Publication 20140051174A1 · Feb 20, 2014